胰高血糖素样肽1受体激动剂周制剂的Mini卫生技术评估 点击下载
| 论文标题： | 胰高血糖素样肽1受体激动剂周制剂的Mini卫生技术评估 |
| 英文标题： | |
| 中文摘要： | 目的 对我国上市的4种胰高血糖素样肽1受体激动剂（GLP-1RA）周制剂进行综合评估，为医院优化药品目录和临床合理用药提供依据。方法采用Mini卫生技术评估法，参照《中国医疗机构药品评价与遴选快速指南》建立评价细则，从药学特性、有效性、安全性、经济性、其他属性5个维度对4种GLP-1RA周制剂进行综合评价。结果4种GLP-1RA周制剂的Mini卫生技术评分从高至低依次为度拉糖肽78.60分、司美格鲁肽77.35分、聚乙二醇洛塞那肽67.40分、艾塞那肽微球65.50分。其中，度拉糖肽在降糖获益、动脉粥样硬化性心血管疾病获益、肾病获益、经济性方面有优势；司美格鲁肽在降糖减重方面有优势，但经济性低于度拉糖肽；艾塞那肽微球在儿童人群中使用有优势，但日均治疗费用最高；聚乙二醇洛塞那肽需要进一步的临床证据。结论4种GLP-1RA周制剂总体均具有较高的综合分值，其中度拉糖肽和司美格鲁肽可能具有更全面的药学价值，而艾塞那肽微球针对儿童人群具有唯一性。 |
| 英文摘要： | OBJECTIVE To comprehensively evaluate four weekly preparations of glucagon-like peptide-1 receptor agonist （GLP-1RA） marketed in China，and to provide evidence for hospitals to optimize drug catalogs and clinical rational drug use. METHODS Mini health technology assessment method was used to establish detailed evaluation rules according to A Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions， and conduct comprehensive evaluation of four GLP- 1RA weekly preparations from aspects of pharmaceutical characteristics， effectiveness， safety， economy and other attributes. RESULTS Mini health technology assessment scores of the four GLP-1RA weekly preparations from high to low were dulaglutide 78.60 points， semaglutide 77.35 points，polyethylene glycol loxenatide 67.40 points， and exenatide microspheres 65.50 points， respectively. Dulaglutide had advantages in reducing blood sugar， arteriosclerotic cardiovascular disease， kidney benefits， and cost- effectiveness. Semaglutide had advantages in reducing blood sugar and weight loss， but its cost-effectiveness was lower than that of dulaglutide. Exenatide microspheres had advantages in the use of children， but its daily average treatment cost is the highest. Polyethylene glycol loxenatide needed further clinical evidence. CONCLUSIONS Four GLP-1RA weekly preparations all have high pharmaceutical comprehensive scores. Dulaglutide and semaglutide may have more comprehensive pharmaceutical value among them， while the use of exenatide microspheres for children is unique. |
| 期刊： | 2023年第34卷第14期 |
| 作者： | 黄文娟；崔梦茹；阿卜杜如苏力·吾舒尔；赵生俊 |
| 英文作者： | HUANG Wenjuan，CUI Mengru，Abudurusuli•Wushuer，ZHAO Shengjun |
| 关键字： | 胰高血糖素样肽1受体激动剂；Mini卫生技术评估；司美格鲁肽；度拉糖肽；艾塞那肽微球；聚乙二醇洛塞那肽 |
| KEYWORDS： | glucagon-like peptide-1 receptor agonist； Mini health technology assessment； semaglutide； dulaglutide； exenatide |
| 总下载数： | 81次 |
| 本日下载数： | 2次 |
| 本月下载数： | 81次 |
| 文件大小： | 619.60Kb |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！